Molson Coors Appeals National Advertising Division Recommendation to Discontinue “Light Beer Shouldn’t Taste Like Water” Claim

New York, NY – February 23, 2023 – In a Fast-Track SWIFT challenge brought by Anheuser-Busch Companies LLC, the National Advertising Division (NAD) of BBB National Programs recommended that Molson Coors Beverage Company discontinue the claim that “light beer shouldn’t taste like water. It should taste like beer.”

Fast-Track SWIFT is an expedited challenge process designed for single-issue advertising cases brought to NAD. Anheuser-Busch challenged Molson Coors’s claim that “light beer shouldn’t taste like water. It should taste like beer” in advertising promoting Miller Lite.

In this challenge, NAD determined that, in context, “light beer shouldn’t taste like water. It should taste like beer” is not puffery or a mere opinion. Although no specific competing light beer is identified by name in the challenged videos, NAD determined that tasting “like water” is a measurable attribute. Reliable sensory testing could demonstrate whether consumers detect a watery taste or the complete absence of taste. Consumers may also reasonably expect that the statement is supported by such evidence. 

Because Molson Coors did not submit evidence supporting the claim that any other light beers “taste like water,” NAD recommended that the claim be discontinued. 

NAD noted that nothing in its decision precludes Molson Coors from making other truthful and not misleading claims relating to consumers’ taste preferences or other claims pertaining to the taste qualities of its beers or competing beers.

NAD determined that the Anheuser-Busch challenge was appropriate for Fast-Track SWIFT because it presented the single issue as to whether the challenged claim was misleading.

In its advertiser statement, Molson Coors stated that it “disagrees with the decision and recommendation of the National Advertising Division and will appeal the decision to the National Advertising Review Board” based on its belief that “the ads do not expressly identify Michelob Ultra or any other light beers” and it should not be precluded from publicly sharing its “opinion” that light beer should not taste like water.

Appeals of NAD decisions are made to BBB National Programs’ National Advertising Review Board (NARB), the appellate-level truth-in-advertising body of BBB National Programs.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary